<DOC>
	<DOCNO>NCT02364388</DOCNO>
	<brief_summary>Imagio breast imaging system , opto-acoustic ( OA ) image system design concurrently collect image conjunction diagnostic ultrasound ( co-registered OA B-mode imaging ) . This medical device CE-marking approve use Europe nation . This post-market , non-randomized multi-center surveillance study .</brief_summary>
	<brief_title>IMAging With Opto-acoustics downgradE BI-RADS claSsificaTion Relative tO Other Diagnostic Methodologies ( MAESTRO )</brief_title>
	<detailed_description>This post-market surveillance study prospective , control , multi-center , observational , evaluate Imagio OA downgrade BI-RADS ( Breast Imaging-Reporting Data System ) classification follow CDU ( Conventional Diagnostic Ultrasound ) visualization characterization suspicious mass prior core needle biopsy ( CNB ) excision . Investigators perform CDU reach diagnosis decision biopsy . Imagio OA use reason perform defer CNB ( Core Needle Biopsy ) excision .</detailed_description>
	<criteria>Inclusion Criteria Female 18 year age old Have undiagnosed suspicious finding may include one solid complex cystic suspicious mass , classify CDU BIRADS 4a 4b within 3 week baseline Imagio Scan Have condition impediment could interfere intended field view ( within one probe length 4 cm mass ) , ( i.e. , breast implant within previous 12 month , tattoo ) Pregnant lactate Patient receive chemotherapy type cancer within 90 day date screening CDU</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>breast imaging diagnosis</keyword>
	<keyword>breast ultrasound</keyword>
	<keyword>Imagio</keyword>
	<keyword>Seno Medical Instruments , Inc .</keyword>
	<keyword>Seno</keyword>
	<keyword>opto-acoustics</keyword>
	<keyword>OA</keyword>
</DOC>